Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.36 |
| ▸ | PRKDC | P78527 | 6/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 3/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.35 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 2/20 | 0.30 |
| ▸ | PIK3CG | P48736 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24028518 | 0.93 | ALOX5 (0.39) | ALOX5PRKDCPIK3CBPIK3CDGGPS1 | |
| SCHEMBL24029053 | 0.90 | MAPT (0.33) | TSHRMAPTMAPK1NPSR1HSD17B10 | |
| SCHEMBL16810905 | 0.90 | ALOX5 (0.41) | ALOX5PRKDCPIK3CBPIK3CDGGPS1 | |
| SCHEMBL16811061 | 0.89 | ALOX5 (0.39) | ALOX5PRKDCPIK3CBPIK3CDGGPS1 | |
| SCHEMBL16810977 | 0.88 | ALOX5 (0.43) | ALOX5PRKDCPIK3CBPIK3CDGGPS1 | |
| SCHEMBL24028514 | 0.88 | PIK3CA (0.38) | PRKDCPIK3CBPIK3CDPIK3CAPIK3CG | |
| SCHEMBL24028640 | 0.86 | MAPT (0.35) | PIK3CBTSHRMAPTMAPK1NPSR1 | |
| SCHEMBL24028639 | 0.86 | MAPT (0.35) | PIK3CBATMTSHRMAPTMAPK1 | |
| SCHEMBL24028560 | 0.86 | ALOX5 (0.37) | ALOX5PRKDCPIK3CBPIK3CDGGPS1 | |
| SCHEMBL16810913 | 0.85 | ALOX5 (0.37) | ALOX5PRKDCPIK3CBPIK3CDGGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210359215-A1 | COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210359215-A1 | COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, SIRT1 | ALOX5 207/4885PRKDC 3964/4885PIK3CB 4226/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.